Rationale: Remote ischemic preconditioning (rIPC) with short episodes of ischemia/reperfusion (I/R) of an organ remote from the heart is a powerful approach to protect against myocardial I/R injury. The signal transduction pathways for the cross talk between the remote site and the heart remain unclear in detail.
R emote ischemic preconditioning (rIPC) has been demonstrated to reduce myocardial ischemia/reperfusion (I/R) injury by short episodes of I/R of an organ distant to the heart (eg, the arm, before a sustained ischemic myocardial ischemia). [1] [2] [3] [4] [5] Previous studies support a translation into clinical practice, 4, [6] [7] [8] and recent studies even demonstrated improved prognosis in patients with acute myocardial infarction or undergoing elective interventional or surgical coronary revascularization. 3, 9 Three components of rIPC can be distinguished: the signal generation, the transfer of the signal to the target organ, and its response to the transferred signal resulting in cardioprotection. The underlying mechanisms of rIPC have not been identified in detail to date. Both humoral factors [10] [11] [12] [13] and neuronal transmission, 14, 15 as well as their interaction, 16 have been hypothesized to forward the protective signal to the heart. Given that the cardioprotective effects can be simulated by transfusing blood from preconditioned donor animals to unconditioned recipients in both in vivo and ex vivo preparations, 10 the contribution of a blood-borne signaling factor seems likely. 7 We have previously observed in humans that a short episode of forearm I/R through blood pressure cuff inflation and deflation is capable of modulating the composition of nitric oxide (NO • )/nitrite levels in the blood compartment. 17, 18 Nitrite is not only the oxidation product of NO
• but also a key reservoir for NO • in blood and cellular compartments and detectable at stable levels over time. 19, 20 The largest component of the bodily nitrite provision derives from endogenous NO
• generation and a smaller part is related to nutritional sources, in particular dietary inorganic nitrate. The exact half-life of nitrite in plasma is not known but calculated for humans to be ≈35 minutes. 21 We and others have recently demonstrated that exogenous supplementation with near physiological nitrite doses has implications for tissue protection under pathological conditions. This pertains to single nitrite injections, chronically administered nitrite, 17, [22] [23] [24] [25] [26] [27] [28] [29] and remarkably also to nitrite administered before the onset of ischemia. 26 Finally, we recently demonstrated that nitrite contributes at physiological levels to the mechanisms causing vessels to dilate when challenged with hypoxia. 30 
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To assess whether the rIPC maneuver has a significant effect on the circulating nitrite pool with a potential benefit for tissue protection, we first tested in healthy volunteers whether the ischemic phase or the reactive hyperemia with the resulting shear stress during rIPC are responsible for the modulation of plasma nitrite levels using 4 cycles of arm I/R. In an experimental approach combining pharmacological and genetic techniques, we determined that endothelial NO synthase (eNOS) in the endothelium is responsible for nitrite generation during reactive hyperemia, which is then readily transported to the myocardium. In an additional approach, we assessed the response of the target organ to the transferred signal. Taking advantage of the myoglobin (Mb) knockout mouse (complete genetic Mb knockout, Mb −/− ), we demonstrated that the nitrite generated during reactive hyperemia is converted to bioactive NO
• with subsequent modification of mitochondria by S-nitrosation, which then ultimately confer the cardioprotective effects. 31 Transfer experiments with plasma from healthy volunteers subjected to rIPC in the arm identified nitrite as a cardioprotective agent in isolated mouse hearts with I/R.
Methods

Human Subjects
Only male participants were enrolled in this study. The protocol was approved by the institutional review board as an amendment of the study Internal No. 3276 (Ethikkommission of the Medical Faculty, Heinrich-Heine-University Duesseldorf). All participants were healthy and without cardiovascular risk factors (smoking, hypertension, and hyperlipidemia) and gave written consent to the participation of the study. Subjects were asked to fast for 12 hours before the study. All tests were conducted between 7.00 and 11.00 am. On arrival at the laboratory, the participants were requested to rest in supine position before a blood sample was drawn from the cubital vein. Fifteen minutes later, the protocol of rIPC was conducted by placing a standard blood pressure cuff on the right upper arm. Arm occlusion was achieved by cuff inflation to 200 mm Hg and confirmed by laser Doppler perfusion imaging and ultrasound (arteria brachialis, 12 MHz linear probe, GE vivid I to measure diameter, peak, and mean flow velocity). All ultrasound measurements were undertaken on longitudinal sections. Based on these measurements, we calculated the wall shear stress. Calculations for blood flow were conducted by multiplication of the mean flow velocity and area. 32 On completion of the protocol, a second blood sample was drawn.
Statistical Analyses
The results are presented as mean±SD. Data were analyzed by ANOVA and post hoc Tukey or Bonferroni comparison tests with GraphPad Prism 6 software to compare differences between multiple groups and Student unpaired t test when analyzing 2 groups. A value of P<0.05 was considered statistically significant.
Details on chemicals, mice, rIPC and I/R protocols, determination of nitrite levels and the circulating and tissue NO
• pool, mitochondrial analyses, and transfer experiments are presented in the Online Data Supplement.
Results
Nitrite Generation by rIPC in Healthy Volunteers Depends on Shear Stress During Reactive Hyperemia
To investigate the ability of rIPC to generate bioactive amounts of nitrite in humans, male healthy volunteers were subjected to a standard rIPC protocol ( Figure 1A-1C) . A blood pressure cuff was placed around the upper right arm and inflated to 200 mm Hg for 5 minutes followed by 5 minutes of cuff deflation for a total of 4 cycles. Before and after the procedure, blood was taken from the contralateral antecubital vein to measure plasma nitrite levels using gas-phase chemiluminescence. 33 The tissue perfusion during the rIPC maneuver was controlled by laser Doppler perfusion imaging on the distal forearm. In addition, a 12-MHz ultrasound probe was placed on the brachial artery distal to the cuff. We compared controls with individuals undergoing rIPC with full reactive hyperemia and individuals undergoing rIPC without reactive hyperemia (reactive hyperemia was inhibited by reducing the diameter of the brachial artery by gentle pressure with the ultrasound probe to ≥50% of its diameter with venous flow left unaltered; scheme in Figure 1B ). Prevention of reactive hyperemia was used to inhibit an increase in shear stress and subsequent eNOS-derived nitrite generation. Compared with baseline, rIPC increased blood volume flow and was associated with a calculated wall shear stress of 106.5±7.78 dynes/cm 2 in the brachial artery, whereas inhibition of reactive hyperemia was associated with a shear stress of 49.27±5.44 dynes/cm 2 . Compared with controls and those without reactive hyperemia, only individuals undergoing rIPC with full reactive hyperemia had significantly increased nitrite levels (basal versus rIPC: 18±8 versus 29±5 nmol/L; P<0.05; Figure 1D -1F). The data without reactive hyperemia by a mechanical maneuver to reduce reperfusion point to endothelial shear stress as the main generator of nitrite with rIPC. To explore the involvement of the myocardial eNOS in the generation of nitrite, we investigated the phosphorylation status of the serine/threonine protein kinases Akt (protein kinase B) and Erk (extracellular signal-regulated kinase) after the rIPC maneuver that promotes eNOS activation. rIPC did not trigger the phosphorylation of Akt and Erk. Likewise, administration of carboxy-2-phenyl-4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-oxide (cPTIO) and nitrite did not lead to any detectable changes in the myocardium before ischemia (data not shown). 
Nitrite Formation From eNOS-Derived NO • and Accumulation in the Myocardium
For further mechanistic insight on the contribution of reactive hyperemia-induced eNOS activity, we performed experiments using the NO
• scavenger cPTIO or eNOS −/− mice. Intubated and mechanically ventilated mice were studied in supine position, and a small cuff was placed tightly around the right upper hind limb. A digital manometer permitted control of occlusion pressure. The same rIPC protocol as in humans was applied (Figure 2A and 2B). Figure 2C shows that plasma nitrite was markedly increased in mice undergoing rIPC (rIPC versus control: 511±132 versus 362±82 nmol/L; P<0.05). Pharmacological NO
• scavenging by prior intravenous (1 mg/kg) cPTIO abolished this effect by prevention of NO
• oxidation to nitrite. If nitrite is generated at the remote site and then transferred humorally to the heart, we would expect a subsequent increase in myocardial nitrite. Remarkably, myocardial nitrite levels were elevated after the stimulus (rIPC versus control: 884±168 versus 532±146 nmol/L; P<0.05). In eNOS −/− mice, this increase in plasma and myocardial nitrite levels was completely abolished ( Figure 2D ). These studies point to eNOS as an indispensable mechanism for nitrite generation and accumulation of nitrite in the myocardium.
Requirement for Nitrite in rIPC-Induced Infarct Size Reduction
To address the relevance of the rIPC-induced nitrite formation with subsequently increasing cardiac nitrite levels, we next determined infarct size in vivo. 29 Experiments were performed in mice undergoing 30-minute regional myocardial ischemia and 24-hour reperfusion with or without rIPC and using the NO scavenger cPTIO and mice without eNOS. Infarct size was determined morphologically (representative micrographs in Online Figure I ). An overview of the experimental approaches is given in Figure 3A . We first tested the effects of rIPC on infarct size reduction in both wild types. rIPC reduced infarct size in NMRI (naval medical research institute) wild-type Remote ischemic preconditioning (rIPC) generates nitrite. Nitrite generation by rIPC was assessed in healthy human volunteers. A, Scheme illustrating the experimental setting. A blood pressure cuff was placed on the upper right arm, and perfusion was monitored distally by laser Doppler perfusion imaging (LDPI). The cuff was inflated to 200 mm Hg for 5 minutes (ischemia, I), followed by 5 minutes of deflation (reperfusion, R). An ultrasound probe was placed on the brachial artery. Using this approach, 3 groups were studied (protocol in B). Group 1 served as control (n=6), whereas groups 2 (n=6) and 3 (n=6) received the rIPC stimulus. In contrast to group 3 with full R, in group 2 R and thus reactive hyperemia were limited by manual compression with the ultrasound probe. C, Exemplary registration showing brachial artery diameter and relative volume flow increase during the first 120 seconds of reperfusion. D, In control subjects (CTRL), no differences in LDPI signal (at reperfusion), flow velocity (basal vs reperfusion), and nitrite concentrations were determined. Top, Original graphs for LDPI and ultrasound pulsed-wave Doppler for basal and poststimulus conditions, whereas the lower graphs depict means±SD for flow and nitrite concentrations. E and F, Abolishing hyperemia does not affect nitrite levels after the rIPC protocol. However, regular reperfusion with reactive hyperemia significantly increased plasma nitrite levels after rIPC (n=6; *P<0.05; unpaired Student t test).
mice ( Figure 3B ; control versus rIPC: 37±4% versus 17±3% of area at risk; P<0.001). In mice where NO • was scavenged, no effect on infarct size was determined. Accordingly, rIPC reduced infarction in C57BL/6 wild types, whereas removal of the femoral nerve had no detectable effect on infarct size and rIPC-mediated cardioprotection was preserved (Online Figure  II ; control versus rIPC versus rIPC after femoral nerve dissection: 41±5% versus 24±3% versus 23±3% of area at risk; P<0.001 comparing the 2 rIPC groups with controls). Finally, genetic ablation of eNOS completely abolished cardioprotection by rIPC ( Figure 3C ). These results also show that cPTIO alone does not affect infarct size. We next determined whether equivalent amounts of exogenous nitrite matching the increase of endogenous nitrite levels with rIPC would mimic cytoprotection. We administered 4.8 nmoles of nitrite intravenously (tail vein) as a 100-μL bolus 5 minutes before ischemia. This demonstrates that supplementation with rIPC-matched nitrite levels simulates cardioprotection seen with rIPC (Online Figure III) . eNOS −/− mice treated with exogenous nitrite also had decreased infarct size and thus remained responsive to nitrite (Online Figure IV) .
Intracellular Activation of the Transfer Signal Nitrite by Mb
We next analyzed the response caused by the transferred nitrite signal within the target organ and the subsequent cardiomyocyte signaling. We have previously shown that Mb is indispensable for the reduction of nitrite in the reperfused myocardium. 29, 34 We, therefore, subjected Mb −/− mice to rIPC followed by in vivo I/R (experimental scheme in Figure 4A ). Transgenic Mb knockout mice were reported to be viable, fertile, without any obvious signs of functional limitation, and behave normally. As compensatory mechanisms, Mb −/− mice exhibit elevated hemoglobin concentrations, increased coronary flow, as well as higher density of capillaries, compared with their wild-type littermates.
35 Figure 4B and 4C shows an increase of nitrite 
Human Plasma Nitrite From Remote Conditioning Protects From Experimental I/R Injury
To address the relevance for a transferable blood-borne factor by rIPC, ex vivo experiments using mouse hearts (Langendorff preparations) subjected to conditioned human blood were conducted. As demonstrated by us and others, circulating nitrite levels in the investigated species range at ≈20 to 50 nmol/L in humans and ≈300 to 500 nmol/L in mice. 36, 37 Considering that after 40 minutes (ie, 4 cycles of ischemia and 4 cycles of reperfusion of each 5-minute duration) most nitrite will escape the circulation and accumulate in tissue and organs, as seen in the mouse myocardium in vivo, a modified protocol had to be applied. We, therefore, applied a single cycle of rIPC (5-minute ischemia) in humans and took blood from the ipsilateral antecubital vein after 1-minute reperfusion ( Figure 6A ). Arguably, this approach allowed us to collect all generated nitrite from the draining vein before it is readily distributed throughout the circulation and every organ. However, this would also apply to all other potential rIPC mediators that have previously been proposed. On the ipsilateral arm, nitrite in plasma increased to a concentration of 162±58 nmol/L, which has been demonstrated to be protective in mice. Plasma, processed by filtration, was then perfused via a perfusion line in admixture with Krebs-Henseleit buffer into the isolated mouse hearts. To determine whether rIPC-generated nitrite in human plasma accumulates into the isolated hearts, we measured cardiac nitrite levels and detected an increase of nitrite after rIPC plasma perfusion compared with controls, an effect that was inhibited by pretreatment of conditioned plasma with the nitrite scavenger sulfanilamide ( Figure 6B ) again pointing to an increased uptake of nitrite into the heart. Perfusion of the isolated hearts with the conditioned human plasma reduced infarct size (47±10%-31±4%; P<0.05; Figure 6C ). The cardioprotective effect of the plasma was abolished after pretreatment with sulfanilamide ( Figure 6C ). Using plasma from subjects without reactive hyperemia and less shear stress did not lead to any detectable changes in infarct size when transferred to the isolated mouse heart (54±13%), whereas plasma with exogenous nitrite matched to the concentration achieved during full reactive hyperemia-reduced infarct size (25±3%; Figure 6C ). To confirm further the relevance of generated nitrite for cardioprotection, we increased the endogenous nitrite levels by dietary nitrate supplementation 27 and performed the rIPC procedure. Administration of the conditioned plasma to mouse hearts reduced infarct sizes to 25±3%, and nitrite scavenging with sulfanilamide again abolished these protective effects (data not shown). To prove the relevance of Mb-mediated nitrite reduction, conditioned human plasma was subjected to hearts of Mb −/− mice, which cannot reduce nitrite to bioactive NO
• . This did not result in a detectable cardioprotection (46±8%-42±4%; P=NS; data not shown).
Discussion
The rIPC maneuver by brief I/R episodes in a remote organ provides significant myocardial protection from potentially lethal myocardial I/R injury. Several clinical studies have demonstrated that on application of rIPC, periprocedural myocardial damage was significantly reduced as evidenced by a marked decrease in the release of myocardial biomarkers during vascular, valve, and bypass surgery 5, 6, 38, 39 and during percutaneous coronary interventions. 4, 40 We and others were furthermore able to show that in conjunction with a decrease in myocardial injury biomarkers, rIPC may provide a significant prognostic effect for these patients. 3, 9 Although the cardioprotective properties of rIPC were first reported 2 decades ago, 1 the underlying mechanisms remain incompletely understood with respect to the potential source, the transfer, and to the activated intracellular target signaling in the myocardium. 6, 7, 14, 41 We here describe a role for endothelium-derived nitrite to contribute to the transfer of the protective signal from the remote site to the myocardium at risk, where nitrite is reduced by Mb to cardioprotective NO • . Many different pathways have been proposed to be activated by rIPC, including neuronal and humoral signal transduction mechanisms. Our present observations specifically assess a role for nitrite in rIPC, but it is likely that multiple overlapping enzymatic and nonenzymatic pathways for signal transduction are present in the circulation and the different blood compartments to allow for the graded Figure 6 . Transfer of cardioprotection. A, Blood was obtained from human volunteers after one cycle of the remote ischemic preconditioning (rIPC) stimulus on the rIPC arm (ipsilateral). The resulting plasma was transferred to isolated mouse hearts. B, Infusion of ipsilateral human rIPC plasma to isolated hearts increased cardiac nitrite levels compared with controls (CTRLs) while this increase was abolished after preincubation of plasma with sulfanilamide to scavenge nitrite (n=3-4; *P<0.05; 1-way ANOVA). C, Infarct studies using conditioned human plasma. Conditioned human plasma reduced infarction compared with CTRL. This reduction in infarct size was abolished by nitrite scavenging with sulfanilamide. Plasma from subjects after rIPC without reactive hyperemia did not lead to a detectable protection while this was the case after nitrite had been added to plasma (n=3-5; *P<0.05 compared with non-nitritesupplemented plasma; 1-way ANOVA). AAR indicates area at risk; I, ischemia; and R, reperfusion.
protection response of the heart. These data, therefore, also highlight the potential for blood cells and potentially undiscovered mediators to be involved in rIPC signaling. Additional investigations are needed to compare each of their relative contributions. The key evidence that supports a major contribution of nitrite signaling in rIPC is (1) nitrite is the stable product of NO
• and transported as such in the blood in much higher concentrations compared with nitroso species. 33 Genetic ablation of eNOS abolished the cardioprotective nature of rIPC. (2) Although this may also be related to eNOS in cardiomyocyte and eNOS-dependent nitrite production in the myocardium itself, our results relating to the activation of the Akt pathway demonstrate that rIPC has no detectable effect on the levels of phospho-Akt. This would be expected if eNOS in the cardiomyocyte itself was activated by rIPC and caused the observed increase in cardiac nitrite. However, this does not rule out a role for Akt/Erk signaling in the reperfused myocardium. The relative contributions of these pathways, which are potentially receptor mediated, must be evaluated in future studies, particularly because a cross talk between the nitrite/NO
• pathway and many other signal transduction systems may exist, as recently demonstrated for ischemic conditioning. 42 (3) In our experiments, plasma from conditioned participants pretreated with sulfanilamide that scavenges all nitrite abolished cardioprotection, whereas replenishment with exogenous nitrite simulated the rIPC effects. (4) In Mb −/− mice, which cannot activate nitrite to NO • , 29, 30, 34, 43 no effect on infarct size was detectable.
rIPC-Dependent Nitrite Generation and Signal Transfer to the Target Organ
The first studies to test how the protective signal is transferred from the remote tissue to the target organ involved pharmacological ganglion blockade and defined a role for a nerval signal transmission. 15 However, porcine studies argued against a mere transmission via the nervous system by demonstrating that the cardioprotective effects of rIPC are active in animals with transplanted and thus denervated hearts. 44 This was further evidenced by studies that transfused conditioned plasma to naive recipient hearts with subsequent reduction in myocardial injury, 11 thus arguing in favor of a humoral factor. Arguably, the rIPC maneuver exerts direct and indirect effects on the vasculature by repetitive sets of short ischemia and reactive hyperemia in the reperfusion phases. Increased blood flow to the arm or hind limb, respectively, in conjunction with increased shear stress is the major stimulus for eNOS to generate NO • and nitrite, the more stable oxidation form. 45 In a first strategy, we aimed to investigate whether the rIPC maneuver producing high levels of shear stress can modulate nitrite in the blood of healthy volunteers and whether this is related to the reactive hyperemia phase. Inhibition of reactive hyperemia markedly reduced the level of shear stress and nullified the generation of nitrite in the course of rIPC, thus precluding a direct contribution of the ischemic phase to the increase of plasma nitrite (eg, through ischemia-induced tissue damage). Taking advantage of the eNOS −/− mouse, as well as through pharmacological scavenging, we provided evidence that abrogation of nitrite generation through NO
• production abolished the cardioprotective effects from rIPC. Furthermore, a specific role for cardiac eNOS in producing tissue nitrite can be excluded by lack of change in phosphorylation of Akt in the myocardium after the rIPC maneuver. These results argue against an eNOS-derived NO
• production within the cardiomyocytes. Nitrite, in turn, has been demonstrated to modulate vascular functions. However, this relates particularly to higher pharmacological doses, 46 whereas the effects of the nitrite levels at baseline and as modulated by rIPC do not change vascular tone and the corresponding blood pressures. The effects of these endogenous moderately increased levels are limited to events of ischemia and hypoxia where nitrite serves as a selective hypoxic NO • donor. 30, 47 This argues in favor of a direct effect of nitrite on the myocardium during I/R rather than one secondary to more favorable hemodynamics. One limitation of our current study is the lack of nitrite measurements in the myocardium of humans. Arguably, the absolute circulating values in humans and mice differ in our study. However, after the rIPC protocol consisting of 4 phases of limb ischemia (5 minutes) followed by 5 minutes of reperfusion, we determined a significant increase in circulating nitrite levels in both our experimental approaches and the intervention trial, which in relative terms was comparable. The generated nitrite is readily distributed throughout all organs and thus escapes the circulation. In our experimental studies in mice, we showed that nitrite accumulates in the heart. We furthermore showed, in a proof-of-concept approach, that nitrite generated by rIPC in humans is cardioprotective. After 4 cycles of rIPC, most nitrite will have escaped the circulation. We, therefore, decided to obtain the plasma after 1 cycle from the ipsilateral arm. However, this does not preclude any other potential mediators generated in the course of rIPC. Although the protective effects of rIPC can be transferred with plasma between men and mice, with abrogation of cardioprotection because of prior nitrite scavenging, differences in nitrite levels between human participants and mice must be acknowledged. Future studies on the cardioprotective effects of nitrite are currently undertaken, and dose responses of nitrite on cardioprotection in humans remain to be defined. As we show here, relatively high concentrations of nitrite are necessary to be cardioprotective. This may be one reason why in an early report from the Nitrites In Acute Myocardial Infarction (NIAMI) trial no evidence for a benefit of a 5-minute intravenous infusion of 70 μmol sodium nitrite before reperfusion in the general population has been seen. 48 
Signal Transfer and Transduction Into Cardioprotection
We next aimed to assess whether the nitrite signal is effectively transported to the heart, leading to a nitrite-dependent cardioprotection signaling during myocardial I/R. Nitrite is regarded as a reservoir for NO • , which is selectively activated under physiological 30, 36 and pathophysiological conditions. 27, 43, 49 We here demonstrate that the rIPC stimulus leads to a transfer of nitrite to the myocardium where it is then reduced by Mb to bioactive NO
• , confirming our previously published results for exogenously supplemented nitrite. 29, 34 Subsequent S-nitrosation of mitochondrial complex I finally led to a reduction of reactive oxygen species in the reperfused myocardium at risk as downstream correlate. This is, therefore, also the first demonstration that rIPC activates a signal transduction machinery to downregulate mitochondrial function by S-nitrosation, recently emerging as a key event for cardioprotection. 29, 31, 49, 50 A potential effect on I/R-induced mitochondrial damage or turnover would also be an important aspect, and future studies are needed.
Taken together, the present findings imply a significant contribution for eNOS-derived nitrite to transfer the protective signal from the remote region to the heart, where it is reduced by Mb to bioactive NO
• , ultimately contributing to infarct size reduction by rIPC. Although many mechanisms that have previously been forwarded may work alongside the proposed one, our present studies show a marked effect on infarct size reduction and may also explain why the effect of rIPC in humans is not as pronounced, 4 given that endothelial function is partly impaired in patients with atherosclerosis and subsequent coronary artery disease.
